Teligent, Inc. (NASDAQ:TLGT) shot up 6.5% on Monday . The company traded as high as $4.07 and last traded at $4.07. 889,693 shares changed hands during trading, an increase of 106% from the average session volume of 432,428 shares. The stock had previously closed at $3.82.

A number of research firms have recently weighed in on TLGT. Canaccord Genuity set a $4.00 price target on Teligent and gave the company a “hold” rating in a report on Saturday. Zacks Investment Research cut Teligent from a “hold” rating to a “strong sell” rating in a report on Saturday, November 11th. Roth Capital set a $9.00 target price on Teligent and gave the stock a “buy” rating in a report on Wednesday, August 23rd. Deutsche Bank dropped their target price on Teligent from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Monday, August 14th. Finally, TheStreet cut Teligent from a “c-” rating to a “d+” rating in a report on Wednesday, November 1st. Three analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $7.00.

The company has a debt-to-equity ratio of 2.23, a quick ratio of 2.71 and a current ratio of 3.28.

Teligent (NASDAQ:TLGT) last announced its earnings results on Monday, November 6th. The company reported ($0.08) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.01) by ($0.07). Teligent had a negative return on equity of 6.51% and a negative net margin of 16.95%. The firm had revenue of $13.65 million for the quarter, compared to the consensus estimate of $19.12 million. During the same period in the previous year, the firm earned $0.01 EPS. Teligent’s revenue for the quarter was down 15.5% on a year-over-year basis. equities analysts expect that Teligent, Inc. will post -0.2 EPS for the current fiscal year.

Large investors have recently made changes to their positions in the stock. Voya Investment Management LLC raised its holdings in Teligent by 16.1% during the second quarter. Voya Investment Management LLC now owns 23,342 shares of the company’s stock worth $214,000 after purchasing an additional 3,234 shares in the last quarter. Renaissance Technologies LLC bought a new position in shares of Teligent in the first quarter valued at $198,000. Aperio Group LLC bought a new position in shares of Teligent in the second quarter valued at $256,000. State of Wisconsin Investment Board bought a new position in shares of Teligent in the second quarter valued at $284,000. Finally, Parametric Portfolio Associates LLC increased its holdings in shares of Teligent by 85.6% in the second quarter. Parametric Portfolio Associates LLC now owns 34,549 shares of the company’s stock valued at $316,000 after buying an additional 15,933 shares in the last quarter. 70.83% of the stock is currently owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: This story was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright law. The legal version of this story can be read at

Teligent Company Profile

Teligent, Inc is a specialty generic pharmaceutical company. Under the Company’s own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 16 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2016.

Receive News & Ratings for Teligent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent Inc. and related companies with's FREE daily email newsletter.